Target intelligence / Profile preview

Copper-dependent enzymes

Molecular classification
Enzyme, Metalloenzyme
01

Overview

Copper-dependent enzymes, also known as cuproenzymes, are a diverse group of proteins that utilize copper ions as essential cofactors to catalyze critical biochemical reactions, particularly those involving oxygen and electron transfer (Lutsenko, 2010, NIH). Key members of this class include cytochrome c oxidase for mitochondrial respiration, superoxide dismutase 1 (SOD1) for antioxidant defense, and lysyl oxidase (LOX) for the cross-linking of collagen and elastin in the extracellular matrix (UniProt). Dysregulation of copper homeostasis or genetic mutations in these enzymes lead to severe pathologies, including Wilson disease (copper overload), Menkes disease (copper deficiency), and various cancers where copper promotes angiogenesis and metastasis (StatPearls). Therapeutic strategies targeting this class include chelating agents like penicillamine to remove excess copper and novel ionophores like elesclomol that induce a copper-dependent form of regulated cell death known as cuproptosis in cancer cells (Tsvetkov et al., 2022, Science). Because copper is a fundamental trace element, pharmacological modulation must be carefully managed to avoid systemic deficiency, which can manifest as hematological disorders or irreversible neurological damage.

Other names
CuproenzymesCopper-containing enzymesCopper metalloenzymes
02

Mechanism of action

Copper chelation to reduce systemic or local copper levels; Copper ionophore-mediated transport to induce cuproptosis; Direct inhibition of specific cuproenzyme catalytic sites.

03

Biological functions

Redox reactionsCellular respirationAntioxidant defenseNeurotransmitter synthesisConnective tissue formationIron homeostasisPigment synthesis
04

Disease associations

Wilson diseaseMenkes diseaseCancerNeurodegenerative diseaseCardiovascular diseaseAmyotrophic lateral sclerosis
05

Safety considerations

Systemic copper deficiencySideroblastic anemiaNeutropeniaNeurological deterioration (paradoxical worsening in Wilson disease)Off-target chelation of zinc or iron
06

Interacting drugs

Penicillamine

5 more in the full profile.

07

Biomarkers

Serum copper levelsSerum ceruloplasmin24-hour urinary copper excretionNon-ceruloplasmin bound copper (Free copper)

Beyond the preview

Go deeper on Copper-dependent enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Copper-dependent enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call